首页> 美国卫生研究院文献>Journal of Clinical Medicine >Characteristics of Critically Ill Patients with COVID-19 Compared to Patients with Influenza—A Single Center Experience
【2h】

Characteristics of Critically Ill Patients with COVID-19 Compared to Patients with Influenza—A Single Center Experience

机译:与流感 - 单一中心经验患者的Covid-19患者的特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Infections with SARS-CoV-2 spread worldwide early in 2020. In previous winters, we had been treating patients with seasonal influenza. While creating a larger impact on the health care systems, comparisons regarding the intensive care unit (ICU) courses of both diseases are lacking. We compared patients with influenza and SARS-CoV-2 infections treated at a tertiary care facility offering treatment for acute respiratory distress syndrome (ARDS) and being a high-volume facility for extracorporeal membrane oxygenation (ECMO). Patients with COVID-19 during the first wave of the pandemic (n = 64) were compared to 64 patients with severe influenza from 2016 to 2020 at our ICU. All patients were treated using a standardized protocol. ECMO was used in cases of severe ARDS. Both groups had similar comorbidities. Time in ICU and mortality were not significantly different, yet mortality with ECMO was high amongst COVID-19 patients with approximately two-thirds not surviving. This is in contrast to a mortality of less than 40% in influenza patients with ECMO. Mortality was higher than estimated by SAPSII score on admission in both groups. Patients with COVID-19 were more likely to be male and non-smokers than those with influenza. The outcomes for patients with severe disease were similar. The study helps to understand similarities and differences between patients treated for severe influenza infections and COVID-19.
机译:在2020年初,SARS-COV-2的感染在全球范围内传播。在以前的冬季,我们一直在治疗季节性流感的患者。在为医疗保健系统创造更大的影响时,缺乏关于两种疾病的重症监护单位(ICU)课程的比较。我们将患有流感和SARS-COV-2感染的患者与急性呼吸窘迫综合征(ARDS)进行治疗,并成为体外膜氧合(ECMO)的高容量设施。在大流行病(N = 64)的第一波卷中的Covid-19患者将与2016年到2020年的64名严重流感的患者进行比较。所有患者均使用标准化方案治疗。 ECMO用于严重ARDS的情况。两组都有类似的合并症。 ICU和死亡率的时间没有显着差异,但在Covid-19患者中,ECMO的死亡率高约有三分之二的患者尚未幸存。这与Ecmo患者患者的死亡率相比,小于40%的死亡率。两组入院的Sapsii评分估计的死亡率高。患有Covid-19的患者更有可能是男性和非吸烟者而非流感的患者。严重疾病患者的结果相似。该研究有助于了解对严重流感感染和Covid-19治疗的患者之间的相似性和差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号